Headlines:
Search for Healthcare Articles by Healthcare Occupations

Generic Pharmaceutical Executives


< Previous   Page 2 of 17   Next >
Search returned 166 items.
sort by:   Title | Author | Publication | Date

Culture Shock- The withdrawal of Vioxx signaled a sea change. Welcome to the Culture of Drug Safety

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442280

Harbingers of Change

What to watch—and watch out for—in the bottom half of '07
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442283

Take Me to Your Leader

Turnover in the top 10 has new CEOs racing to reinvent the way their companies do business. But who has the courage to lead the industry itself back to greatness?
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442281

Deals: Actavis Going Private?

Maybe, but not yet, as the board of the Icelandic generics maker holds out for a better offer
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=442279

VIDEO Exclusive Video Interview with CDER Director, Steven Galson, MD VIDEO

Exclusive Video Interview with CDER Director, Steven Galson, MD on Drug Risks, Regulation and Research
http://www.advanstar.com/test/pharmascience/pha-sci_supp-promos/phasci_reg_guid

COURT SHOOTS DOWN GENERIC FOR LIPITOR

The US patent for Lipitor is not due to expire until March 2010, but Ranbaxy had sought to market a generic version prior to that date. The Supreme Court's action shuts the door on that effort.
http://www.pharmacytimes.com/Article.cfm?Menu=1&ID=4659

Leadership: Outsmarting Your Competitors

Gaining market share isn't something you do only once—think of it as running a race with no finish line
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=429151

Push is on for research on comparative effectiveness

What works best in drugs, devices, biologicals, and procedures
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=423919

2006 Rx market flashback: Generics take the lead, brands fall off, blockbusters were absent last year

Credit for the lopsided win for generics goes to the relative balance in New Drug Approvals (18) and patent expirations (19) in 2006.
http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id=414440

New FDA rules aim to limit conflict of interest

Financial ties to drug companies may bar experts from advising agency
http://www.msnbc.msn.com/id/17722620/
< Previous   Page 2 of 17   Next >
Search returned 166 items.
Sponsored Links
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
Place your ad in this
Must-Read Pharma Mag
www.biotechmedia.com